Twist Bioscience (TWST) Non-Current Assets (2018 - 2026)

Twist Bioscience has disclosed Non-Current Assets across 9 years of filings, most recently posting $352.8 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 37.17% year-over-year to $352.8 million; the TTM figure through Mar 2026 stood at $1.3 billion (up 22.12% YoY), while the FY2025 annual figure was $308.9 million, up 15.45% from the prior year.
• Non-Current Assets advanced to $352.8 million in Q1 2026, from $334.2 million in the prior quarter.
• Over the last five years, Non-Current Assets for TWST reached as high as $368.1 million in Q4 2022 and fell as low as $257.2 million in Q1 2025.
• The 5-year median for Non-Current Assets is $342.6 million (2023), against an average of $327.3 million.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 415.6% — and 2024, when it slipped 24.26%.
• A 5-year view of Non-Current Assets shows it stood at $368.1 million in 2022, then declined by 6.93% to $342.6 million in 2023, then decreased by 23.15% to $263.3 million in 2024, then climbed by 26.94% to $334.2 million in 2025, then climbed by 5.56% to $352.8 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $352.8 million, $334.2 million, and $308.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.